Media

Interview with Daniela Marino on CNN Money Switzerland

Switzerland is perfect for Startups, but… Switzerland boasts some of the best skills in the world, according to Daniela Marino. The Cutiss CEO says Switzerland is also the “perfect place” to be an entrepreneur. So what’s the catch? When it comes to money, Swiss investors aren’t as willing to take risks as their American counterparts.

Interview mit Daniela Marino auf CNN Money Switzerland.

©CUTISS

Interview with Daniela Marino on Moneycab.com

“The B round will need to provide 30-40 million CHF to support the market access.”

by Patrick Gunti

Moneycab.com: Ms. Marino, Cutiss has developed a revolutionary method to produce human skin in the lab. How did that happen?
In 2001 the Tissue Biology Reseach Unit, a research lab of the Department of Surgery of the University Children’s hospital in Zurich started working on skin bio-engineering to solve an unmet clinical need mostly connected to burns. Unfortunately, standard of care to treat large, deep burns is scarce and ineffective leading very often to highly debilitating, disfiguring scarring. Via personalized skin tissue bio-engineering one could permanently treat large wound surfaces and minimize the scarring.

Forbes article about CUTISS “La peau sur mesure”

Article in French only.

Start-up suisse créée en 2017 et spécialisée dans la biotechnologie, CUTISS AG est une jeune entreprise adossée à l’Université de Zürich. Son application ? La peau ! Spécialisée dans la reconstitution de peau sur-mesure, Cutiss travaille main dans la main avec des hôpitaux européens, Suisses, Hollandais et Anglais, et travaille déjà à son futur : démocratiser la fabrication de peau pour les grands blessés et pour toutes les autres personnes ayant besoin d’une greffe de peau.

CUTISS AG on ntv Start-up News

News from the startup scene: Ideas that nobody used to have, products that were not feasible at the time, companies that can only emerge now – all this and more can be found in the Startup News (in German only)

NZZ article “University invests in their Spin-offs”

The newly founded
UZH Life Science Fund invests around one million francs in the
Spin-off Cutiss. The University
Zurich is thus breaking new ground.
The goal is to develop the skin substitutes of the young company quickly to make them ready for the market.
Text: WALTER BERNET
(article in German only)

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

This website uses cookies to ensure you get the best experience on our website.